# Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery

> **NCT02531724** · PHASE4 · COMPLETED · sponsor: **Sahlgrenska University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Acute Kidney Injury
- Renal Insufficiency, Acute

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02531724
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531724, "Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02531724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*